Angiotensin II deteriorates advanced atherosclerosis by promoting MerTK cleavage and impairing efferocytosis through the AT<sub>1</sub>R/ROS/p38 MAPK/ADAM17 pathway

Yan Zhang(Zunyi Medical University), Zuyi Yuan(First Affiliated Hospital of Xi'an Jiaotong University)
American Journal of Physiology-Cell Physiology
August 7, 2019
10.1152/ajpcell.00145.2019
Cited by 69

Related Papers

Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial
|The Lancet|2023|139
Association of Blood Pressure Trajectories in Early Life with Subclinical Renal Damage in Middle Age
|Journal of the American Society of Nephrology|2018|102
Endothelial-derived extracellular microRNA-92a promotes arterial stiffness by regulating phenotype changes of vascular smooth muscle cells
|Scientific Reports|2022|34
IL-17 intensifies IFN-γ-induced NOS2 upregulation in RAW 264.7 cells by further activating STAT1 and NF-κB
|International Journal of Molecular Medicine|2015|25
Myofibroblast YAP/TAZ is dispensable for liver fibrosis in mice
|Journal of Hepatology|2021|14